drugset
drugset / Trial / NCT01657240

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis

NCT01657240 ↗

Phase 3 Withdrawn Laboratorios Sophia S.A de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the clinical efficacy of the ophthalmic solution PRO-118 compared with olopatadine hydrochloride ophthalmic solution in allergic conjunctivitis.

Timeline

Start
2014-11
Primary completion
2015-04
Completion
2015-05

Outcome

Outcome not reported

Stopped: “Formula Reformulation”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olopatadine Other / unclassified — Other
Subject PRO-118 Unknown — Other

Indications

conjunctivitis